Related Experiment Video
Updated: Dec 23, 2025

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
Published on: June 18, 2020
Viscoelastic test-based bleeding risk score reliably predicts coagulopathic bleeding in decompensated cirrhosis and
Chhagan Bihari1, Anupama Patil1, Saggere Muralikrishna Shasthry2
1Department of Pathology and Hematology, Institute of Liver and Biliary Sciences, D1, Vasant Kunj, New Delhi, India.
Insights
A new viscoelasticity-based bleeding risk score using activated clotting time (ACT), platelet function (PF), and fibrinogen effectively predicts coagulopathic bleeding in decompensated cirrhosis (DC) patients.
Area of Science:
- Hepatology
- Coagulation Science
- Medical Diagnostics
Background:
- Predicting coagulopathic bleeding in decompensated cirrhosis (DC) is challenging with conventional assays.
- Viscoelastic tests (VETs) offer a more comprehensive assessment of coagulation status.
- The Sonoclot VET was evaluated for its utility in predicting bleeding events.
Purpose of the Study:
- To investigate the predictive value of Sonoclot VET parameters and fibrinogen for coagulopathic bleeding in DC patients.
- To develop and validate a bleeding risk score for DC patients.
- To assess the score's utility in acute-on-chronic liver failure (ACLF) and its correlation with mortality.
Main Methods:
- Coagulation parameters were measured in 874 patients (compensated cirrhosis, DC, ACLF) and 190 controls.
- Sonoclot variables (ACT, CR, PF, TP, PA) and fibrinogen levels were analyzed.
- A bleeding risk score was developed using Cox regression in a derivation cohort and validated in a separate cohort.
Main Results:
- DC patients exhibited significantly prolonged ACT, longer TP, and smaller PA compared to controls.
- A bleeding risk score incorporating ACT, PF, and fibrinogen accurately predicted coagulopathic bleeding in both derivation and validation cohorts.
- The score was also predictive in ACLF patients, and higher scores correlated with increased 1-year mortality due to bleeding.
Conclusions:
- A viscoelasticity-based bleeding risk score using ACT, PF, and fibrinogen effectively predicts coagulopathic bleeding in DC patients.
- This score can aid in the rational transfusion of blood products.
- The developed score is valuable for predicting bleeding complications in advanced liver disease.
Background And Aims:
Coagulopathic bleeding risk prediction is challenging in decompensated cirrhosis (DC) by conventional assays. Viscoelastic tests (VETs) are likely to be more useful for assessing coagulation status in these patients. We investigated whether the VET (Sonoclot) parameters with fibrinogen could predict coagulopathic bleeding in these patients.
Patients And Methods:
Coagulation parameters studied in 874 patients [124 compensated cirrhosis (CC), 521 DC, and 229 acute-on-chronic liver failure (ACLF)] and 190 controls. DC patients were enrolled in derivation (n = 266) and validation (n = 255) cohorts. Sonoclot variables [activated clotting time (ACT), clot rate (CR), platelet function (PF), time to peak (TP) and peak amplitude (PA)] and fibrinogen levels were measured. Coagulopathic bleeding was recorded along with 1-year survival.
Results:
DC patients had prolonged ACT (p < 0.001), depressed CR (p = 0.059), reduced PF (p = 0.09), longer TP (p < 0.001) and smaller PA (p < 0.001), compared to CC and controls (p < 0.001 each). In derivation cohort, 32.3% patients had coagulopathic bleeding. Cox regression analysis of derivation cohort revealed; ACT > 190 s, PF < 1.25 and fibrinogen < 1.2 g/l could predict coagulopathic bleeding and were used to develop a bleeding risk score. In validation cohort; this score was comparable, correlated to real events, and had similar bleed free events with time. The score was also useful in predicting bleed in ACLF patients. In DC patients, 1-year mortality was higher those who bled and received transfusions.
Conclusion:
Viscoelasticity-based bleeding risk score using ACT, PF and fibrinogen, predicts coagulopathic bleeding in DC patients and should be useful in rationalizing transfusion of blood products. We designed a viscoelastic test-based bleeding risk score which is useful in advanced liver disease to predict the coagulation-related bleeding. This figure shows the lower bleeding-free events in advanced cirrhosis with each incremental bleeding risk score.
Related Concept Videos
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Venous Thrombosis IV: Nursing Management
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

